Seal Rock Therapeutics
Corine brings over 20 years of experience in commercial strategy, market analysis and partnering. She has worked in large multi-national corporations , such as Genentech, Bayer HealthCare, Novartis, and more recently with biotech start-ups. Having spent over 14 years at Genentech, Corine has extensive experience participating on launch teams for Blockbuster products such as Ocrevus, Tecentriq and Kadcyla. Corine also brings extensive experience in asset licensing, as well as a track record for structuring corporate collaborations in a range of therapeutic areas, including oncology, neurological diseases and inflammation.
This person is not in any offices
Seal Rock Therapeutics
1 followers
Seal Rock Therapeutics is a developer of small molecule inhibitors used to treat inflammatory and fibrotic conditions.